Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Consumer Discretionary ETF Vanguard | VCR | Sep 19, 2024 | 337.17 | +2.28 |
Consumer Portfolio Services | CPSS | Sep 19, 2024 | 9.98 | +2.46 |
Consumer Staples Alphadex First Trust | FXG | Sep 19, 2024 | 68.17 | +0.10 |
Consumer Staples ETF Vanguard | VDC | Sep 19, 2024 | 217.97 | -0.42 |
Consumer Staples Select Sector SPDR | XLP | Sep 19, 2024 | 82.65 | -0.59 |
Consumers Energy Pref | CMS-B | Sep 19, 2024 | 82.00 | 0.00 |
Container Store | TCS | Sep 19, 2024 | 14.80 | +4.37 |
Contango ORE | CTGO | Sep 19, 2024 | 18.82 | -1.57 |
Context Therapeutics | CNTX | Sep 19, 2024 | 2.23 | +13.78 |
Contextlogic A | LOGC | Sep 19, 2024 | 5.40 | +0.56 |
Contineum Therapeutics | CTNM | Sep 19, 2024 | 20.08 | +8.60 |
Continuous Commodity Index | GCC | Sep 19, 2024 | 18.76 | +1.46 |
Controladora Vuela Compania de Aviacion ADR | VLRS | Sep 19, 2024 | 6.62 | -1.63 |
Cool Company | CLCO | Sep 19, 2024 | 11.35 | 0.00 |
Cooper-Standard | CPS | Sep 19, 2024 | 14.18 | +5.11 |
Copa | CPA | Sep 19, 2024 | 91.74 | +1.59 |
Copart | CPRT | Sep 19, 2024 | 51.80 | +1.57 |
Corbus Pharmaceuticals | CRBP | Sep 19, 2024 | 51.70 | +4.80 |
Corcept Therapeutics | CORT | Sep 19, 2024 | 40.92 | -3.19 |
Core & Main A | CNM | Sep 19, 2024 | 44.81 | +3.77 |
Core Laboratories | CLB | Sep 19, 2024 | 18.59 | +1.58 |
Core Molding Technologies | CMT | Sep 19, 2024 | 18.49 | +2.72 |
Core Scientific | CORZ | Sep 19, 2024 | 11.61 | -3.49 |
Corebridge Financial | CRBG | Sep 19, 2024 | 27.98 | +3.55 |
CoreCard | CCRD | Sep 19, 2024 | 15.88 | +1.60 |
CoreCivic | CXW | Sep 19, 2024 | 12.73 | -1.16 |
CorMedix | CRMD | Sep 19, 2024 | 7.01 | -3.24 |
Corner Growth Acquisition 2 A | TRON | Sep 19, 2024 | 11.50 | 0.00 |
Corner Growth Acquisition Unit | COOLU | Sep 19, 2024 | 11.40 | 0.00 |
Cornerstone Stategic | CLM | Sep 19, 2024 | 7.52 | +0.53 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.